We are moving into the new Health Sciences building in January and this is an exciting time for our researchers and students! You can help by supporting health sciences research. We are seeking philanthropic support to acquire a hybrid multi-mode plate reader (such as BioTek Cytation) that will allow us to:
2. Study and characterize the host-pathogen interactions and development of antibiotic resistance
3. Identify new biological targets (proteins, RNA) for disease prevention and treatment
Chronic diseases, including mitochondrial diseases, metabolic diseases (obesity, type 2 diabetes, cardiovascular disease), inflammatory diseases (obstructive pulmonary disease, arthritis, inflammatory bowel diseases), cancer, and infectious diseases (opportunistic pathogens, antibiotic resistance, HIV/AIDS, hepatitis) cost Canadians more than $250 billion a year, and result in premature deaths, disability, poor quality of life and reduced human capital.
At Carleton’s Department of Health Sciences, we have established an interdisciplinary team of scientists with a goal to prevent and reduce the burden of chronic disease in Canadians. Our researchers and students are taking a lifecourse approach, from before and during pregnancy and childhood, through to the emergence of these diseases in adulthood, to understand and prevent disease.
As we move into the new Health Sciences building we are equipping the labs for research and teaching. Medical research equipment is costly and we are starting with a brand new lab.
This hybrid multi-mode plate reader is a core research module that is upgradable to meet future lab requirements. It supports a variety of experiments and is uniquely designed to support applications across automated digital microscopy and conventional multi-mode detection such as cell based assays, biomarker assays, imaging applications, protein quantification and kinetic assays.
Our goal is to raise $25,000 and to have it matched on Giving Tuesday so that we can purchase this equipment.
We all benefit from the discoveries of health research.
Through our innovative approaches we will uncover the determinants of chronic diseases, be able to predict individuals at-risk for chronic disease in later life and identify new biological targets for disease prevention and treatment.
In the long-term, our work will contribute to preventing and reducing the burden of chronic disease in Canadians and on the Canadian health care system.